• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

油酸对肺表面活性物质的抑制作用:机制与特征

Inhibition of pulmonary surfactant by oleic acid: mechanisms and characteristics.

作者信息

Hall S B, Lu R Z, Venkitaraman A R, Hyde R W, Notter R H

机构信息

Department of Medicine, Oregon Health Sciences University, Portland 97201-3098.

出版信息

J Appl Physiol (1985). 1992 May;72(5):1708-16. doi: 10.1152/jappl.1992.72.5.1708.

DOI:10.1152/jappl.1992.72.5.1708
PMID:1601776
Abstract

The inhibitory effects of oleic acid (OA) on the surface activity of pulmonary surfactant were characterized by use of the oscillating bubble surfactometer, the Wilhelmy balance, and excised rat lungs. Oscillating bubble studies showed that OA prevented lavaged calf surfactant [0.5 mM phospholipid (PL)] from lowering surface tension below 15 mN/m at or above a molar ratio of OA/PL = 0.5. In contrast to inhibition of surfactant by plasma proteins, increasing the surfactant concentration did not eliminate inhibition by oleic acid, which occurred at OA/PL greater than 0.67 on the oscillating bubble even at surfactant concentrations of 1.5 and 12 mM PL. Studies of surfactant adsorption showed that preformed films of OA had little effect on the adsorption of pulmonary surfactant. Wilhelmy balance studies showed that OA did interfere with the ability of spread films of surfactant to reach low surface tensions during dynamic compression. Further balance experiments with binary films of OA and dipalmitoyl phosphatidylcholine showed that these compounds were miscible in surface films. Together these findings suggested that OA inhibited pulmonary surfactant activity by disrupting the rigid interfacial film responsible for the generation of very low surface tension during dynamic compression. Mechanical studies in excised rat lungs showed that instillation of OA gave altered deflation pressure-volume characteristics with decreased quasi-static compliance, indicating disruption of pulmonary surfactant function in situ. This alteration of mechanics occurred without major changes in the composition of lavaged PLs or in the tissue compliance of the lungs defined by mechanical measurements during inflation-deflation with saline.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

通过使用振荡气泡表面活性剂测定仪、威廉米天平以及离体大鼠肺,对油酸(OA)对肺表面活性剂表面活性的抑制作用进行了表征。振荡气泡研究表明,在油酸与磷脂(PL)的摩尔比为0.5或更高时,油酸可阻止灌洗后的小牛表面活性剂[0.5 mM磷脂(PL)]将表面张力降低至15 mN/m以下。与血浆蛋白对表面活性剂的抑制作用不同,增加表面活性剂浓度并不能消除油酸的抑制作用,即使在表面活性剂浓度为1.5 mM和12 mM PL时,在振荡气泡上,当油酸与磷脂的摩尔比大于0.67时仍会出现抑制作用。表面活性剂吸附研究表明,预先形成的油酸膜对肺表面活性剂的吸附影响很小。威廉米天平研究表明,油酸确实会干扰表面活性剂铺展膜在动态压缩过程中达到低表面张力的能力。进一步用油酸和二棕榈酰磷脂酰胆碱的二元膜进行的天平实验表明,这些化合物在表面膜中是可混溶的。这些研究结果共同表明,油酸通过破坏在动态压缩过程中负责产生极低表面张力的刚性界面膜来抑制肺表面活性剂活性。对离体大鼠肺的力学研究表明,滴注油酸会改变放气压力-容积特性,准静态顺应性降低,表明原位肺表面活性剂功能受到破坏。这种力学改变在灌洗的磷脂组成或通过盐水充气-放气过程中的力学测量所定义的肺组织顺应性方面没有重大变化的情况下发生。(摘要截断于250字)

相似文献

1
Inhibition of pulmonary surfactant by oleic acid: mechanisms and characteristics.油酸对肺表面活性物质的抑制作用:机制与特征
J Appl Physiol (1985). 1992 May;72(5):1708-16. doi: 10.1152/jappl.1992.72.5.1708.
2
Primary importance of zwitterionic over anionic phospholipids in the surface-active function of calf lung surfactant extract.两性离子磷脂在小牛肺表面活性剂提取物表面活性功能中比阴离子磷脂具有首要重要性。
Am J Respir Crit Care Med. 1997 Oct;156(4 Pt 1):1049-57. doi: 10.1164/ajrccm.156.4.96-10077.
3
Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity.血红蛋白和细胞膜脂质对肺表面活性物质活性的影响。
J Appl Physiol (1985). 1987 Oct;63(4):1434-42. doi: 10.1152/jappl.1987.63.4.1434.
4
Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs.一种抗磷脂酶的合成表面活性剂在大鼠肺中的活性及抗抑制性
Am J Respir Cell Mol Biol. 2007 Oct;37(4):387-94. doi: 10.1165/rcmb.2006-0434OC. Epub 2007 Jun 7.
5
Multiple mechanisms of lung surfactant inhibition.肺表面活性物质抑制的多种机制。
Pediatr Res. 1999 Jul;46(1):85-93. doi: 10.1203/00006450-199907000-00015.
6
Dynamic surface activity of films of lung surfactant phospholipids, hydrophobic proteins, and neutral lipids.肺表面活性物质磷脂、疏水蛋白和中性脂质膜的动态表面活性。
J Lipid Res. 1995 Jun;36(6):1283-93.
7
Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.疏水载脂蛋白作为临床外源性表面活性剂成分的重要性。
Am Rev Respir Dis. 1992 Jan;145(1):24-30. doi: 10.1164/ajrccm/145.1.24.
8
Biophysical inhibition of synthetic lung surfactants.合成肺表面活性剂的生物物理抑制作用。
Chem Phys Lipids. 1990 Feb;52(3-4):243-50. doi: 10.1016/0009-3084(90)90120-g.
9
Content of dipalmitoyl phosphatidylcholine in lung surfactant: ramifications for surface activity.肺表面活性物质中双棕榈酰磷脂酰胆碱的含量:对表面活性的影响
Pediatr Res. 1996 May;39(5):805-11. doi: 10.1203/00006450-199605000-00010.
10
Inhibition of pulmonary surfactant function by meconium.胎粪对肺表面活性物质功能的抑制作用。
Am J Obstet Gynecol. 1991 Feb;164(2):477-81. doi: 10.1016/s0002-9378(11)80003-7.

引用本文的文献

1
The Synthetic Surfactant CHF5633 Restores Lung Function and Lung Architecture in Severe Acute Respiratory Distress Syndrome in Adult Rabbits.合成表面活性剂 CHF5633 可恢复成年兔严重急性呼吸窘迫综合征的肺功能和肺结构。
Lung. 2024 Jun;202(3):299-315. doi: 10.1007/s00408-024-00689-z. Epub 2024 Apr 29.
2
Activity and biophysical inhibition resistance of a novel synthetic lung surfactant containing Super-Mini-B DATK peptide.一种含有超微型B DATK肽的新型合成肺表面活性剂的活性及生物物理抑制抗性
PeerJ. 2016 Jan 5;4:e1528. doi: 10.7717/peerj.1528. eCollection 2016.
3
Meconium-induced inflammation and surfactant inactivation: specifics of molecular mechanisms.
胎粪诱导的炎症和表面活性剂失活:分子机制的细节
Pediatr Res. 2016 Apr;79(4):514-21. doi: 10.1038/pr.2015.265. Epub 2015 Dec 17.
4
Exposure to polymers reverses inhibition of pulmonary surfactant by serum, meconium, or cholesterol in the captive bubble surfactometer.暴露于聚合物可逆转血清、胎粪或胆固醇在人工泡沫表面张力计中对肺表面活性剂的抑制作用。
Biophys J. 2012 Oct 3;103(7):1451-9. doi: 10.1016/j.bpj.2012.08.024. Epub 2012 Oct 2.
5
Increased phospholipase A2 and lyso-phosphatidylcholine levels are associated with surfactant dysfunction in lung contusion injury in mice.在小鼠肺挫伤损伤中,增加的磷脂酶 A2 和溶磷脂酰胆碱水平与表面活性剂功能障碍有关。
Surgery. 2013 Jan;153(1):25-35. doi: 10.1016/j.surg.2012.05.043. Epub 2012 Jul 31.
6
Surfactant therapy for acute lung injury and acute respiratory distress syndrome.表面活性物质治疗急性肺损伤和急性呼吸窘迫综合征。
Crit Care Clin. 2011 Jul;27(3):525-59. doi: 10.1016/j.ccc.2011.04.005.
7
The biophysical function of pulmonary surfactant.肺表面活性物质的生物物理功能。
Respir Physiol Neurobiol. 2008 Nov 30;163(1-3):244-55. doi: 10.1016/j.resp.2008.05.018. Epub 2008 Jul 16.
8
Surfactant for pediatric acute lung injury.用于小儿急性肺损伤的表面活性剂
Pediatr Clin North Am. 2008 Jun;55(3):545-75, ix. doi: 10.1016/j.pcl.2008.02.016.
9
Dynamic surface activity of a fully synthetic phospholipase-resistant lipid/peptide lung surfactant.一种完全合成的抗磷脂酶脂质/肽肺表面活性剂的动态表面活性
PLoS One. 2007 Oct 17;2(10):e1039. doi: 10.1371/journal.pone.0001039.
10
Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs.一种抗磷脂酶的合成表面活性剂在大鼠肺中的活性及抗抑制性
Am J Respir Cell Mol Biol. 2007 Oct;37(4):387-94. doi: 10.1165/rcmb.2006-0434OC. Epub 2007 Jun 7.